Literature DB >> 21093220

Trajectories of the course of schizophrenia: from progressive deterioration to amelioration over three decades.

Stephen Z Levine1, Ido Lurie, Robert Kohn, Itzhak Levav.   

Abstract

BACKGROUND: The extent of heterogeneity in the long-term course of schizophrenia is unclear. AIMS: To examine the course of schizophrenia in a population-based cohort.
METHODS: This study included all Israeli individuals born in 1970-1988, of North African or European origin (N=2290), entered in the National Psychiatric Hospitalization Case Registry with a last discharge diagnosis of schizophrenia (1978-2004) and followed to 2009. Linked socio-demographic information was extracted from the Population Registry. Based on the number of hospitalized days at each age, trajectory groups were empirically derived, plotted and compared on psychiatric hospitalization measures of the course of illness, social factors and family stressors.
RESULTS: Trajectory analysis identified four course groups. Group I (57%) assumed a prototypical course, had an average first hospitalization age of 20, deteriorated until 23 and then ameliorated. Group II (15.5%) assumed an early-onset protracted course, had an average first hospitalization age of 17.1, and deteriorated until 21. Group III (15%) assumed a late-onset with longest deterioration period course, had an average first hospitalization age of 22.7, and deteriorated until 29. Group IV (12%) assumed an early-onset refractory illness course, had an average first hospitalization age of 18, and had the longest hospitalization period. Groups significantly differed on hospitalization (i.e., onset), social (i.e., socioeconomic and ethnic status) and familial factors (i.e., parental death). Despite group differences all deteriorated and then ameliorated on average by the age of 23.
CONCLUSIONS: The course of schizophrenia was heterogeneous, yet evolved from deterioration to assume a course consistent with amelioration.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21093220     DOI: 10.1016/j.schres.2010.10.026

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  17 in total

1.  Cluster analysis of cognitive deficits may mark heterogeneity in schizophrenia in terms of outcome and response to treatment.

Authors:  Elsa Gilbert; Chantal Mérette; Valérie Jomphe; Claudia Emond; Nancie Rouleau; Roch-Hugo Bouchard; Marc-André Roy; Thomas Paccalet; Michel Maziade
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-10-31       Impact factor: 5.270

Review 2.  The effects of aging on insight into illness in schizophrenia: a review.

Authors:  Philip Gerretsen; Eric Plitman; Tarek K Rajji; Ariel Graff-Guerrero
Journal:  Int J Geriatr Psychiatry       Date:  2014-07-23       Impact factor: 3.485

Review 3.  Antipsychotic dosing: found in translation.

Authors:  Gary Remington; Gagan Fervaha; George Foussias; Ofer Agid; Peter Turrone
Journal:  J Psychiatry Neurosci       Date:  2014-07       Impact factor: 6.186

Review 4.  Modeling heterogeneous patients with a clinical diagnosis of schizophrenia with induced pluripotent stem cells.

Authors:  Kristen J Brennand; Melissa A Landek-Salgado; Akira Sawa
Journal:  Biol Psychiatry       Date:  2013-11-15       Impact factor: 13.382

5.  Subtyping Schizophrenia by Treatment Response: Antipsychotic Development and the Central Role of Positive Symptoms.

Authors:  Jimmy Lee; Hiroyoshi Takeuchi; Gagan Fervaha; Gwen Li Sin; George Foussias; Ofer Agid; Saeed Farooq; Gary Remington
Journal:  Can J Psychiatry       Date:  2015-11       Impact factor: 4.356

6.  Characteristics of immigrant and non-immigrant patients in a dual-diagnosis psychiatric ward and treatment implications.

Authors:  Sophie D Walsh; David Blass; Meital Bensimon-Braverman; Lee Topaz Barak; Yael Delayahu
Journal:  J Immigr Minor Health       Date:  2014-12

7.  Response trajectories to clozapine in a secondary analysis of pivotal trials support using treatment response to subtype schizophrenia.

Authors:  William G Honer; Andrea A Jones; Allen E Thornton; Alasdair M Barr; Ric M Procyshyn; Fidel Vila-Rodriguez
Journal:  Can J Psychiatry       Date:  2015-03       Impact factor: 4.356

Review 8.  Information for mental health systems: an instrument for policy-making and system service quality.

Authors:  A Lora; A Lesage; S Pathare; I Levav
Journal:  Epidemiol Psychiatr Sci       Date:  2016-10-26       Impact factor: 6.892

9.  Changing trends in hospitalization rates associated with psychosis: Spain, 1980-2009.

Authors:  Alvaro Medel-Herrero; J M Amate; Z Saz-Parkinson; M Gómez-Beneyto
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2015-09-28       Impact factor: 4.328

10.  Differences in views of schizophrenia during medical education: a comparative study of 1st versus 5th-6th year Italian medical students.

Authors:  Lorenza Magliano; John Read; Alessandra Sagliocchi; Melania Patalano; Antonio D'Ambrosio; Nicoletta Oliviero
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2012-11-02       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.